TROG Cancer Research
Members Login   CQMS Login

TD 17.03 (LARK)

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)


Liver Ablative Radiotherapy utilizing Kilovoltage intrafraction monitoring 


This study aims to show that incorporating Kilovoltage Intrafraction monitoring (KIM) in to liver SABR improves: treatment accuracy, patient treatment outcomes, and treatment efficiency

Opening to recruitment

Approximately Quarter 2, 2018

Trial chairperson

Dominique Lee, Crown Princess Mary Cancer Centre, Westmead

Trial contact

Rebecca Montgomery
Clinical Trials Project Manager
TROG Trial Coordinating Centre
Phone: +61 2 4014 3910

Trial resources for TROG members

TD 17.03 member page


We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.